Butterfly Network (NYSE:BFLY) announced today that it partnered with Ambra Health (an Intelerad company) to improve interoperability for bedside imaging data.
The partnership aims to accelerate and simplify bedside imaging data interoperability by strengthening the scalability of Butterfly’s Blueprint enterprise platform and enhancing access to and shareability of valuable ultrasound information across hospitals and health systems.
Guilford, Connecticut–based Butterfly said in a news release that it plans to utilize Ambra’s background in bringing disparate imaging information together in a streamlined, efficient manner across large health systems. Together, the companies intend to unlock real-time information and drive better clinical decision-making through enhanced online data integration for ultrasound information.
“Our partnership with Ambra Health furthers our goal for Butterfly to become a foundational platform to leading healthcare institutions,” Butterfly Network Chief Strategy & Business Development Officer Darius Shahida said in the release. “Leveraging Ambra’s capabilities in medical data management, our Blueprint platform can now more seamlessly integrate as part of the clinical workflows and with the many systems that care teams depend on. This partnership will greatly accelerate the transformational potential Butterfly can have across hospitals and health systems, and across the industry at large.”
The companies expect the integrated solution to be made commercially available during the first quarter of 2022. They will offer it to both new and existing enterprise clients.
“We are excited to partner with Butterfly Network and believe the value our two companies bring to hospitals and health systems will be significant,” Intelerad President Morris Panner said. “Encounter-based imaging has the power to transform diagnostics and care delivery. Ambra’s cloud-based technological underpinning is poised to speed realization of this potential.”
